cochlear implant
FDA Approved, CE Marked
Description
Cochlear implants are surgically implanted electronic devices that provide a sense of sound to individuals with severe to profound sensorineural hearing loss. The device bypasses damaged portions of the inner ear and directly stimulates the auditory nerve. It is indicated for both congenital and acquired hearing loss when conventional hearing aids provide insufficient benefit.
Indications & Therapeutic Use
Severe to profound sensorineural hearing loss, congenital deafness, autosomal recessive nonsyndromic deafness
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
cochlear implant
| Generic Name | cochlear implant |
| Brands | 1 brand available |
| Drug Class | Severe to profound sensorineural hearing loss |
| Manufacturer | Cochlear Limited |
| Dosage Forms | Implantable device |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 30 days |
| Reg. Status | FDA Approved, CE Marked |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes